Personalized CRT - PSR
Trial ID or NCT#
NCT03723265
Status
RECRUITING
Purpose
The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.
Official Title
Personalized CRT - Product Surveillance Registry (PSR)
Eligibility Criteria
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements - Patient has or is intended to receive or be treated with an eligible CRT device - Patient within 30 days of therapy received at the time of their initial PSR platform enrollment
Exclusion Criteria:
- - Patient who is, or is expected to be inaccessible for follow-up - Patient with exclusion criteria required by local law - Patient is currently enrolled in or plans to enroll in any concurrent drug and/ or device study that may confound results
View on ClinicalTrials.gov